comprehensive -WSS

comprehensive

author：explore 2025-10-01 04:10:28 - browse：71592

Novo Nordisk headquarters -- health coverage from STAT — LISELOTTE SABROE/Scanpix/AFP via Getty Images

The Danish pharmaceutical company Novo Nordisk has shepherded all kinds of medical innovation in the 110 years since it was founded. But the booming success of its diabetes and obesity drug is unlike anything executives have seen before.

The company’s mid-year operating profit jumped from 37.5 billion Danish kroner in 2022 to 48.9 billion Danish kroner this year — “probably the strongest growth in the history of the company,” Chief Financial Officer Karsten Munk Knudsen said during an August earnings call. The 30% growth rate came from sales of semaglutide, which Novo Nordisk sells for diabetes under the name Ozempic and for obesity as Wegovy.

With its new blockbuster drug in hand, Novo Nordisk is valued higher than the entire economy of Denmark, where it’s based.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Health Care Service Corp to buy Cigna Medicare Advantage plans

WSS

How dance can help nurses traumatized by Covid

Startup Neumora takes a novel depression drug to Phase 3

Sanofi seeks simpler, safer CRISPR sickle cell cure

How generative AI ratchets up security threats for health systems

In early work, researchers turn to CRISPR to treat Alzheimer's

Listen: Wegovy in the brain & pivotal Alzheimer's data

hotspot

comprehensive

Wikipedia

In age of alternative facts, a scholarly course on calling out crap

In early work, researchers turn to CRISPR to treat Alzheimer's

Continuity nursing helped my family in our darkest PICU moments

A public scorecard can help hold safety

In Memoriam: Notable people who died in 2023

In early work, researchers turn to CRISPR to treat Alzheimer's

State Dept. review finds Biden bears some blame for Afghanistan failures

Merck, Johnson & Johnson CEOs will testify on high drug prices

Heart attack and stroke risk calculators need revising

At Orexo, a ‘turning point’ for everything but digital health

entertainment

Investment in vaccine development is lagging, report finds

10 reasons why health care startups fail

How dance can help nurses traumatized by Covid

Biden tests positive for Covid

Biden tests positive for Covid

How Medicaid coverage policies for immigrants impact new moms

focus

focus

entertainment

focus